Lisa van der Schee, Krijn Jan Cornelis Haasnoot, Sjoerd G Elias, Kim Gijsbers, Y A Alderlieste, Yara Backes, Annemarie M van Berkel, Femke Boersma, F Ter Borg, Emilie C H Breekveldt, Koen Kessels, Miriam Koopman, Iris Lansdorp-Vogelaar, Monique E van Leerdam, Gertjan Rasschaert, Ramon Michel Schreuder, R W M Schrauwen, Tom C J Seerden, Marcel B W Spanier, Jochim S Terhaar Sive Droste, Esther Toes-Zoutendijk, Jurriaan Tuynman, Geraldine R Vink, Wouter H de Vos Tot Nederveen Cappel, Frank P Vleggaar, M M Lacle, Leon Mg Moons
BACKGROUND AND STUDY AIMS: The incidence of T1 colorectal cancers (CRC) has increased with the implementation of CRC screening programs. It is unknown if outcomes and and risk models for T1 CRC patients, based on non-screen-detected cases, can be extrapolated to screen-detected T1 CRC. This study aims to compare stage distribution and oncological outcomes of T1 CRC patients within and outside the screening program. PATIENTS AND METHODS: Data from T1 CRC patients diagnosed between 2014-2017 were collected from 12 hospitals in the Netherlands...
February 7, 2024: Endoscopy